Skip to content
knowrare
HealthSignal
Your condition community

Living with Glutamate pyruvate transaminase 2 deficiency

A rare genetic nervous system condition with a small head, low muscle tone in infancy, and later stiffness in the legs.

Understanding Glutamate pyruvate transaminase 2 deficiency

Glutamate pyruvate transaminase 2 deficiency is a rare genetic neurological disorder that begins in infancy.

Babies have a head that grows slowly after birth (microcephaly) and low muscle tone (hypotonia). Most then develop growing stiffness (spasticity), mainly in the legs, with spastic diplegia or paraplegia, intellectual disability, delayed or absent speech, and slurred speech. Some have seizures.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Small head size (microcephaly)
  • Very low muscle tone in infancy
  • Stiff legs and trouble walking (spastic paraplegia)
  • Intellectual disability
  • Delayed or absent speech
  • Global developmental delay

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in GPT2 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    Spastic Paraplegia Foundation may keep lists of experts for this condition.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Expert lists: Spastic Paraplegia Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Spastic Paraplegia Foundation
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Can genetic testing confirm a change in the GPT2 gene?
Which therapies can help with walking, speech, and feeding?
Do we need a neurologist to watch for seizures?

Quick facts

Symptoms usually startInfant
InheritanceAutosomal Recessive
GenesGPT2

Changes in the GPT2 gene cause this condition. A child inherits a changed copy of the gene from each parent (autosomal recessive).

GeneticNeurological

Also known as: gpt2 deficiency; nedspm; neurodevelopmental disorder with microcephaly and spastic paraplegia; postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome

Patient organizations

Broader rare-disease groups

Source: NIH GARD · Glutamate pyruvate transaminase 2 deficiencyGARD ID 17853 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Glutamate pyruvate transaminase 2 deficiency.

Explore the Glutamate pyruvate transaminase 2 deficiency blog

Explore research for Glutamate pyruvate transaminase 2 deficiency

Explore actively recruiting Glutamate pyruvate transaminase 2 deficiency studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Glutamate pyruvate transaminase 2 deficiency with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Glutamate pyruvate transaminase 2 deficiency studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Glutamate pyruvate transaminase 2 deficiency

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Glutamate pyruvate transaminase 2 deficiency

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Glutamate pyruvate transaminase 2 deficiency experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.